When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning
Fundamental & Clinical Pharmacology · 2026-07 · 40 (4)
DOI: 10.1111/fcp.70109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 22.07.2026. Verfasst von Enzo Emanuele und 6 weiteren Autor:innen. Beteiligte Einrichtung: 2E Science, Robbio, Pavia, Italy. Hauptthemen laut MEDLINE: Drug Repositioning, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The systematic conversion of adverse drug reactions (ADRs) into new therapeutic indications represents one of the oldest and most productive sources of repositioned drugs; however, it has not been subjected to formal mechanistic analysis.
Objectives
This study aims to propose a mechanistic taxonomy of convertible ADRs and a structured workflow for translating documented adverse effects into testable repositioning hypotheses.
Methods
In this narrative review, historical cases of ADR‐driven repositioning spanning five decades—from sildenafil and minoxidil to semaglutide—were analyzed and classified within a four‐dimensional framework organized along the axes of: (1) target identity (on‐target versus off‐target conversion); (2) dose, route of administration, and reformulation; (3) patient population and clinical context; and (4) pharmacogenomic variability.
Results
Each historical case was successfully classified within the proposed taxonomy. A five‐step theoretical workflow—comprising signal identification, taxonomic classification, mechanistic verification, feasibility assessment, and preliminary evidence search—was developed to operationalize the framework for prospective hypothesis generation. Computational tools including side‐effect similarity networks, network pharmacology, and transcriptomic signature reversal were identified as means to support specific workflow steps.
Conclusions
The proposed taxonomy and workflow provide a replicable, mechanism‐informed approach to ADR‐driven drug repositioning, while also delineating the pharmacological, regulatory, and methodological challenges that separate a repositioning signal from an approved therapeutic indication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2E Science, Robbio, Pavia, Italy.
- Department of Social Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain.
- Studio Minoretti, Oggiono, Lecco, Italy.
- Center for Research in Medical Pharmacology, University of Insubria, Varese, Italy.
- Cantonal Psychiatric Clinic, Cantonal Sociopsychiatric Organization, Mendrisio, Switzerland.
- i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain.
ORCID-Profile: Enzo Emanuele, Piercarlo Minoretti, Martina Ballerio, Alejandro Santos-Lozano, Simone Lista, Filippo Caraci, Robert Nisticò
Zitieren
APA
Emanuele, E., Minoretti, P., Ballerio, M., Santos-Lozano, A., Lista, S., Caraci, F., & Nisticò, R. (2026). When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning. Fundamental & Clinical Pharmacology, 40(4). https://doi.org/10.1111/fcp.70109
Vancouver
Emanuele E, Minoretti P, Ballerio M, Santos-Lozano A, Lista S, Caraci F, et al. When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning. Fundamental & Clinical Pharmacology. 2026;40(4). doi:10.1111/fcp.70109
BibTeX
@article{Emanuele2026,
author = {Emanuele, Enzo and Minoretti, Piercarlo and Ballerio, Martina and Santos-Lozano, Alejandro and Lista, Simone and Caraci, Filippo and Nisticò, Robert},
title = {When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning},
journal = {Fundamental & Clinical Pharmacology},
year = {2026},
volume = {40},
number = {4},
doi = {10.1111/fcp.70109}
}
EUVIMED